Literature DB >> 18092379

Endogenous vasopressin and copeptin response in multiple trauma patients.

Isabella Westermann1, Martin W Dünser, Thorsten Haas, Stefan Jochberger, Günter Luckner, Viktoria D Mayr, Volker Wenzel, Karl-Heinz Stadlbauer, Petra Innerhofer, Nils Morgenthaler, Walter R Hasibeder, Wolfgang G Voelckel.   

Abstract

Endogenous arginine vasopressin (AVP) levels in multiple trauma patients are unknown. Arginine vasopressin is considered to play an important role in severe hemorrhage. In this prospective study, 87 multiple trauma patients (Injury Severity Score >15) and 50 healthy volunteers were enrolled. On admission to the emergency department (ED), demographic, clinical, and laboratory data were documented, and blood was sampled for determination of AVP (radioimmunosassay) and copeptin, a stable fragment of the AVP precursor (immunoluminometric assay). In patients requiring intensive care unit (ICU) therapy, blood and data sampling were repeated at 4, 6, and 24 h after ED admission. Linear logistic and mixed-effects regression analyses were used for statistical analysis. On ED admission, AVP plasma concentrations (43.2 +/- 84.9 pM) were significantly increased when compared with controls (0.92 +/- 0.44 pM, P < 0.001). Plethysmographic oxygen saturation was the only parameter independently associated with AVP (regression coefficient, -0.126; 95% confidence interval, -0.237 to -0.014; P = 0.03). No correlation was observed between AVP and survival (P = 0.62), hemodynamic variables (systolic arterial pressure, P = 0.24; MAP, P = 0.59; diastolic arterial pressure, P = 0.74; central venous pressure, P = 0.36), or brain trauma (P = 0.46). In ICU patients, AVP decreased during the first 24 h (P < 0.001) and was independently associated with heart rate (P = 0.02) and blood glucose (P = 0.009). Copeptin concentrations were correlated with AVP (r2 = 0.718, P < 0.001). In conclusion, AVP was significantly increased in multiple trauma patients and seems to be an integral part of the neuroendocrine response to severe injury. In ICU patients, AVP decreased to moderately elevated levels within 24 h after ED admission.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18092379     DOI: 10.1097/shk.0b013e3180cab33f

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  17 in total

1.  Impact of low-dose vasopressin on trauma outcome: prospective randomized study.

Authors:  Stephen M Cohn; Janet McCarthy; Ronald M Stewart; Rachelle B Jonas; Daniel L Dent; Joel E Michalek
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

Review 2.  A global perspective on vasoactive agents in shock.

Authors:  Djillali Annane; Lamia Ouanes-Besbes; Daniel de Backer; Bin DU; Anthony C Gordon; Glenn Hernández; Keith M Olsen; Tiffany M Osborn; Sandra Peake; James A Russell; Sergio Zanotti Cavazzoni
Journal:  Intensive Care Med       Date:  2018-06-04       Impact factor: 17.440

3.  Angiotensin AT1A receptors expressed in vasopressin-producing cells of the supraoptic nucleus contribute to osmotic control of vasopressin.

Authors:  Jeremy A Sandgren; Danny W Linggonegoro; Shao Yang Zhang; Sarah A Sapouckey; Kristin E Claflin; Nicole A Pearson; Mariah R Leidinger; Gary L Pierce; Mark K Santillan; Katherine N Gibson-Corley; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-01-24       Impact factor: 3.619

4.  Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study.

Authors:  Belen Ponte; Menno Pruijm; Daniel Ackermann; Philippe Vuistiner; Idris Guessous; Georg Ehret; Heba Alwan; Sonia Youhanna; Fred Paccaud; Markus Mohaupt; Antoinette Péchère-Bertschi; Bruno Vogt; Michel Burnier; Pierre-Yves Martin; Olivier Devuyst; Murielle Bochud
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

5.  Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury.

Authors:  Anatol Manaenko; Nancy Fathali; Nikan H Khatibi; Tim Lekic; Yu Hasegawa; Robert Martin; Jiping Tang; John H Zhang
Journal:  Neurochem Int       Date:  2011-01-20       Impact factor: 3.921

6.  The vasopressin and copeptin response in patients with vasodilatory shock after cardiac surgery: a prospective, controlled study.

Authors:  Stefan Jochberger; Corinna Velik-Salchner; Viktoria D Mayr; Günter Luckner; Volker Wenzel; Gerda Falkensammer; Hanno Ulmer; Nils Morgenthaler; Walter Hasibeder; Martin W Dünser
Journal:  Intensive Care Med       Date:  2008-09-30       Impact factor: 17.440

7.  Copeptin and arginine vasopressin at high altitude: relationship to plasma osmolality and perceived exertion.

Authors:  A J Mellor; C J Boos; S Ball; A Burnett; S Pattman; M Redpath; D R Woods
Journal:  Eur J Appl Physiol       Date:  2014-09-12       Impact factor: 3.078

8.  Modern resuscitation of hemorrhagic shock: what is on the horizon?

Authors:  D T Martin; M A Schreiber
Journal:  Eur J Trauma Emerg Surg       Date:  2014-06-17       Impact factor: 3.693

9.  The prognostic value of plasma Δ-copeptin levels in patients with isolated traumatic brain injury.

Authors:  U Y Cavus; S Yildirim; B Gurer; K Dibek; D Yilmaz; G Ozturk; F Buyukcam; E Sonmez
Journal:  Eur J Trauma Emerg Surg       Date:  2013-12-04       Impact factor: 3.693

10.  Changes and effects of plasma arginine vasopressin in traumatic brain injury.

Authors:  W D Huang; J Pan; M Xu; W Su; Y Q Lu; Z J Chen; T Y Jiang; Y M Yang
Journal:  J Endocrinol Invest       Date:  2008-11       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.